Neogen Corporation (NEOG)

Market Cap	2.05B +12.1%
Revenue (ttm)	870.56M -3.9%
Net Income	-608.84M
EPS	-2.80
Shares Out	217.67M
PE Ratio	n/a
Forward PE	39.25
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,849,509
Open	9.96
Previous Close	10.04
Day's Range	9.29 - 10.00
52-Week Range	4.32 - 11.43
Beta	1.97
Analysts	Buy
Price Target	10.67 (+13.27%)
Earnings Date	Apr 9, 2026

About NEOG

Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and complementary products to detect dangerous and unintended substances in human food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanita...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Aug 23, 1989
• Employees: 2,974
• Stock Exchange: NASDAQ
• Ticker Symbol: NEOG
• Website: https://www.neogen.com

Financial Performance

In fiscal year 2025, Neogen's revenue was $894.66 million, a decrease of -3.20% compared to the previous year's $924.22 million. Losses were -$1.09 billion, 11491.6% more than in 2024.

Analyst Summary

According to 4 analysts, the average rating for NEOG stock is "Buy." The 12-month stock price target is $10.67, which is an increase of 13.27% from the latest price.

Price Target

$10.67

(13.27% upside)

Analyst Consensus: Buy